Emicizumab plasma levels after accelerated saturation in acquired haemophilia A

Author:

Kloeter Tristan12,Keller Maren13,Metze Michael12,Petros Sirak14,Pfrepper Christian1ORCID

Affiliation:

1. Division of Hemostaseology, Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology University of Leipzig Medical Center Leipzig Germany

2. Department of Cardiology University of Leipzig Medical Center Leipzig Germany

3. Department of Anesthesiology University of Leipzig Medical Center Leipzig Germany

4. Medical ICU University of Leipzig Medical Center Leipzig Germany

Publisher

Wiley

Reference10 articles.

1. International recommendations on the diagnosis and treatment of acquired hemophilia A

2. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

3. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

4. Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH‐AH 01/2010 study;Holstein K;Blood,2020

5. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding;Pasca S;Blood Transfus,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3